LT3734B - Use of bambuterol for the manufacture of a pharmaceutical preparation with lipid lowering effect - Google Patents

Use of bambuterol for the manufacture of a pharmaceutical preparation with lipid lowering effect Download PDF

Info

Publication number
LT3734B
LT3734B LTIP1735A LTIP1735A LT3734B LT 3734 B LT3734 B LT 3734B LT IP1735 A LTIP1735 A LT IP1735A LT IP1735 A LTIP1735 A LT IP1735A LT 3734 B LT3734 B LT 3734B
Authority
LT
Lithuania
Prior art keywords
bambuterin
manufacture
cholesterol
bambuterol
lowering effect
Prior art date
Application number
LTIP1735A
Other languages
English (en)
Lithuanian (lt)
Inventor
Carl-Axel Wilhelm Edvard Bauer
Leif Aake Svensson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LTIP1735A publication Critical patent/LTIP1735A/xx
Publication of LT3734B publication Critical patent/LT3734B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LTIP1735A 1990-03-16 1993-12-30 Use of bambuterol for the manufacture of a pharmaceutical preparation with lipid lowering effect LT3734B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use

Publications (2)

Publication Number Publication Date
LTIP1735A LTIP1735A (en) 1995-07-25
LT3734B true LT3734B (en) 1996-02-26

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1735A LT3734B (en) 1990-03-16 1993-12-30 Use of bambuterol for the manufacture of a pharmaceutical preparation with lipid lowering effect

Country Status (28)

Country Link
US (2) US5837727A (xx)
EP (1) EP0521967B1 (xx)
JP (1) JP3081640B2 (xx)
KR (1) KR100194995B1 (xx)
AT (1) ATE138570T1 (xx)
AU (1) AU653149B2 (xx)
CA (1) CA2077762C (xx)
CZ (1) CZ279308B6 (xx)
DE (1) DE69119896T2 (xx)
DK (1) DK0521967T3 (xx)
EG (1) EG19645A (xx)
ES (1) ES2087291T3 (xx)
GR (1) GR3020700T3 (xx)
HK (1) HK52197A (xx)
HU (1) HU211998B (xx)
IE (1) IE80668B1 (xx)
IL (1) IL97509A (xx)
LT (1) LT3734B (xx)
LV (1) LV10917B (xx)
MY (1) MY114218A (xx)
NZ (1) NZ237279A (xx)
PT (1) PT97052B (xx)
RU (1) RU2093153C1 (xx)
SE (1) SE9000948D0 (xx)
SG (1) SG64895A1 (xx)
SK (1) SK278815B6 (xx)
WO (1) WO1991013615A1 (xx)
ZA (1) ZA911452B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
US7067517B2 (en) 2001-12-14 2006-06-27 Nero Nordisk A/S Use of compounds for decreasing activity of hormone-sensitive lipase
ES2312669T3 (es) * 2002-08-08 2009-03-01 Wen Tan R-bambuterol, su preparacion y usos terapeuticos.
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807A2 (en) 1980-07-09 1982-01-13 Aktiebolaget Draco 1-(Dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807A2 (en) 1980-07-09 1982-01-13 Aktiebolaget Draco 1-(Dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
T. GORDON, V.P. KASTELLI, IR KT: "Aukšto tankio lipoproteinai, kaip apsauginis faktorius prieš išeminę širdies ligą, farmacinis tyrmas", AM . J. MED 62, 1977, pages 707 - 714
V.P. KASTELLI, J.T. DOIL IR KT: "ATL-cholesterinas ir kiti lipidai sergant išemine širdies liga", THE COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY, 1997, pages 767 - 772

Also Published As

Publication number Publication date
RU2093153C1 (ru) 1997-10-20
IE80668B1 (en) 1998-11-18
DK0521967T3 (da) 1996-09-09
AU7569191A (en) 1991-10-10
PT97052B (pt) 1998-07-31
ATE138570T1 (de) 1996-06-15
LV10917B (en) 1996-04-20
HU211998B (en) 1996-01-29
JPH05504971A (ja) 1993-07-29
EG19645A (en) 1995-09-30
US6034123A (en) 2000-03-07
SG64895A1 (en) 2000-01-25
IL97509A (en) 1995-12-31
CA2077762A1 (en) 1991-09-17
IE910862A1 (en) 1991-09-25
DE69119896T2 (de) 1996-10-10
SK278815B6 (sk) 1998-03-04
IL97509A0 (en) 1992-06-21
KR100194995B1 (ko) 1999-06-15
CS9100681A2 (en) 1991-10-15
EP0521967B1 (en) 1996-05-29
PT97052A (pt) 1991-10-31
ZA911452B (en) 1991-11-27
CA2077762C (en) 2001-06-12
HUT61461A (en) 1993-01-28
AU653149B2 (en) 1994-09-22
CZ279308B6 (cs) 1995-04-12
MY114218A (en) 2002-09-30
WO1991013615A1 (en) 1991-09-19
SE9000948D0 (sv) 1990-03-16
GR3020700T3 (en) 1996-10-31
NZ237279A (en) 1993-08-26
JP3081640B2 (ja) 2000-08-28
EP0521967A1 (en) 1993-01-13
US5837727A (en) 1998-11-17
DE69119896D1 (de) 1996-07-04
ES2087291T3 (es) 1996-07-16
HK52197A (en) 1997-05-02
LV10917A (lv) 1995-12-20
HU9202958D0 (en) 1992-12-28
LTIP1735A (en) 1995-07-25

Similar Documents

Publication Publication Date Title
AU686706B2 (en) Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
US20040242634A1 (en) Methods for treating prion diseases
JPH1067663A (ja) ミルタザピンと１種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
SA93140384B1 (ar) كربامات الفينيل
JP2004196821A (ja) ベータ−２−気管支拡張薬の改善使用
US20080255079A1 (en) Therapeutic Use of Nefopam and Analogues Thereof
Abe et al. Agents for the treatment of glycosphingolipid storage disorders
Ditschuneit et al. Comparison of different HMG-CoA reductase inhibitors
JPH04225916A (ja) 脂血障害の治療用組成物
LT3734B (en) Use of bambuterol for the manufacture of a pharmaceutical preparation with lipid lowering effect
US20020055533A1 (en) Pharmaceutical composition
Stübner et al. Efficacy and Safety of an Oral Formulation of Cetirizine and Prolonged-release Pseudoephedrine versus Xylometazolin Nasal Spray in Nasal Congestion
US6194460B1 (en) Composition for treating cough induced by angiotensin converting enzyme inhibitors
CA1209047A (en) Therapeutic composition containing piracetam analog
AU2001282541B2 (en) Medicinal compositions
US20060089412A1 (en) Pharmaceutical composition for the treatment of non-alcoholic fatty liver disease
JP2003501385A (ja) Ｈｍｇ−ｃｏａレダクターゼ阻害剤とカルニチン類を含む抗高脂血症性組合せ
EP1245228A2 (en) Medicament for the inducement of cognition enhancement
US4073940A (en) Method for treating cardiac arhythmia by administration of basic aryloxyacetamide
SK18072002A3 (sk) Farmaceutické prípravky obsahujúce betablokátor a ich použitie
Giacomini et al. Ancillary pharmacologic properties of acebutolol: cardioselectivity, partial agonist activity, and membrane-stabilizing activity
KR20010013685A (ko) 케탄제린 및 ｌ-카르니틴 또는 알카노일 ｌ-카르니틴을함유하는 ｃｒｐｓ 치료용 조성물
CA1280695C (en) Nalbuphine-local anesthetic analgesic composition and method of producing analgesia
US5843938A (en) Treatment of atherosclerosis

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19971230